MarketScreener Editorial Features United Therapeutics Corporation
Stocks
UTHR
US91307C1027
Pharmaceuticals
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 547.06 USD | -0.98% |
|
-1.59% | +12.28% |
| 07-10 | Biopharma Pricing Power Seen as Key Swing Factor for Q2 Earnings, BofA Says | MT |
| 07-10 | BofA Securities Adjusts United Therapeutics Price Target to $613 From $620 | MT |
MarketScreener Editorial Features
Search
 | United Therapeutics delivers 18th consecutive quarter of topline growth | June 17, 2025 at 03:39 am |
No results match your criteria
- Stock Market
- Stocks
- UTHR Stock
- News United Therapeutics Corporation
- MarketScreener Editorial Features
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition